PUBLISHER: TechNavio | PRODUCT CODE: 1384507
PUBLISHER: TechNavio | PRODUCT CODE: 1384507
The allergy rhinitis drugs market is forecasted to grow by USD 3.17 bn during 2023-2028, accelerating at a CAGR of 3.92% during the forecast period. The report on the allergy rhinitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of allergy rhinitis, high unmet medical needs, and technological advances in allergy rhinitis diagnostics.
Market Scope | |
---|---|
Base Year | 2023 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 3.54% |
CAGR | 3.92% |
Incremental Value | $3.17bn |
Technavio's allergy rhinitis drugs market is segmented as below:
By Distribution Channel
By Product
By Geographical Landscape
This study identifies the increase in R&D of new therapies as one of the prime reasons driving the allergy rhinitis drugs market growth during the next few years. Also, increasing demand for over-the-counter medicines and an increase in collaborations will lead to sizable demand in the market.
The report on the allergy rhinitis drugs market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading allergy rhinitis drugs market vendors that include ALK Abello AS, Apotex Inc., Bayer AG, Cadila Pharmaceuticals Ltd., Catalent Inc., Dr Reddys Laboratories Ltd., Faes Farma SA, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., HAL Allergy BV, Haleon Plc, Hikma Pharmaceuticals Plc, KYORIN Holdings Inc., Merck and Co. Inc., Mitsubishi Chemical Group Corp., Novartis AG, Sanofi SA, Stallergenes Greer Ltd., Ube Corp., and Viatris Inc.. Also, the allergy rhinitis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: